Galmed Pharmaceuticals Ltd. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Galmed Pharmaceuticals Ltd. Earnings Date And Information
Galmed Pharmaceuticals Ltd. last posted its earnings results on Thursday, April 4th, 2024. The company reported $-0.98 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $0.66. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Galmed Pharmaceuticals Ltd. has generated $-30 earnings per share over the last year ($-29.95 diluted earnings per share) and currently has a price-to-earnings ratio of -0.75. Galmed Pharmaceuticals Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 19th, 2024 based on prior year's report dates.
Galmed Pharmaceuticals Ltd. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
06/29/2024 | Q2 2024 | -$2.13 | $0 | $0 | ||
05/30/2024 | Q1 2024 | -$0.23 | $0 | $0 | ||
04/04/2024 | Q4 2023 | -$0.32 | -$0.40 | -0.08 | $0 | $0 |
11/22/2023 | Q3 2023 | -$0.27 | -$0.24 | 0.03 | $0 | $0 |
06/01/2023 | Q2 2023 | -$1.50 | -$0.95 | 0.55 | $0 | |
06/01/2023 | Q1 2023 | -$1.50 | -$0.99 | 0.51 | $0 | |
03/29/2023 | Q4 2022 | $0.14 | -$1.68 | -1.82 | $0 | |
11/16/2022 | Q3 2022 | -$2.25 | -$3.20 | -0.95 | $0 | |
05/02/2022 | Q2 2022 | -$2.23 | $0 | |||
05/02/2022 | Q1 2022 | -$3.70 | $0 | |||
05/02/2022 | Q4 2021 | -$4.46 | $0 | |||
09/29/2021 | Q3 2021 | -$4.61 | $0 | |||
05/13/2021 | Q2 2021 | -$6.60 | -$5.02 | 1.58 | $0 | |
03/18/2021 | Q1 2021 | -$6.00 | -$5.71 | 0.29 | $0 | |
11/12/2020 | Q4 2020 | -$4.80 | -$7.15 | -2.35 | $0 | |
11/12/2020 | Q3 2020 | -$4.80 | -$4.87 | -0.07 | $0 | |
05/14/2020 | Q2 2020 | -$5.55 | -$3.92 | 1.63 | $0 | |
03/12/2020 | Q1 2020 | -$5.55 | -$4.30 | 1.25 | $0 | |
11/06/2019 | Q4 2019 | -$4.80 | -$5.88 | -1.08 | $0 | |
11/06/2019 | Q3 2019 | -$4.80 | -$3.21 | 1.59 | $0 |
Galmed Pharmaceuticals Ltd. Earnings: Frequently Asked Questions
-
When is Galmed Pharmaceuticals Ltd.'s earnings date?
Galmed Pharmaceuticals Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 19th, 2024 based off last year's report dates.
-
How can I listen to Galmed Pharmaceuticals Ltd.'s earnings conference call?
The conference call for Galmed Pharmaceuticals Ltd.'s latest earnings report can be listened to online.
-
How can I read Galmed Pharmaceuticals Ltd.'s conference call transcript?
The conference call transcript for Galmed Pharmaceuticals Ltd.'s latest earnings report can be read online.
-
How much profit does Galmed Pharmaceuticals Ltd. generate each year?
Galmed Pharmaceuticals Ltd. (:GLMD) has a recorded net income of $0. Galmed Pharmaceuticals Ltd. has generated $-29.95 earnings per share over the last four quarters.
-
What is Galmed Pharmaceuticals Ltd.'s price-to-earnings ratio?
Galmed Pharmaceuticals Ltd. (:GLMD) has a price-to-earnings ratio of -0.75 and price/earnings-to-growth ratio is 0.